Methotrexate Drugs Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Azurity Pharmaceuticals, Inc.
- Cumberland Pharmaceuticals Inc.
- Teva Pharmaceuticals USA, Inc.
- Amneal Pharmaceuticals LLC
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma Limited,
- Sandoz Inc
- Hikma Pharmaceuticals PLC
- Eisai Co., Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of methotrexate drugs is estimated at USD 643.36 million.
The global methotrexate drugs market size was over USD 627.55 million in 2025 and is anticipated to witness a CAGR of around 2.8%, crossing USD 827.14 million revenue by 2035.
North America methotrexate drugs market will hold around 40.8% share by 2035, driven by rising surgical procedures and traffic-related injuries.
Key players in the market include Pfizer Inc., Azurity Pharmaceuticals, Inc., Cumberland Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Sandoz Inc, Hikma Pharmaceuticals PLC, Eisai Co., Ltd.
